Oncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports
Analysts remain positive on Syrah Resources despite current weak market conditions for graphite
Tim Boreham highlights the potential for cancer treatment biotech Arovella Therapeutics
Skin repair specialist PolyNovo remains confident in its firm growth path ahead
New research highlights Retail Food Group’s resilience to a consumer downturn and several capital-light growth opportunities
Brokers explain a negative share price reaction to Johns Lyng’s upgraded FY23 guidance
Recent research on Macquarie Technology shows a strong near-term cloud demand outlook and a significant growth profile in coming years
New research identifies Alcidion Group is attaining scale and becoming profitable at an opportune time for healthcare technology demand
New research on Capricorn Metals anticipates growth potential along with consistent profits and increasing dividends over time
Tim Boreham takes a look at Lumos Diagnostics, which specialises in rapid point-of-care tests to help healthcare professionals diagnose and manage medical conditions more accurately